Case guide

UPDATED FEB 2026

PowerPort MDL Settlement Timeline — What to Expect

Part of the Bard PowerPort Catheter investigation

The short answer

MDL mass tort litigation follows a predictable multi-year progression from case filing through bellwether trials to global settlement. Understanding each phase helps PowerPort plaintiffs set realistic expectations for timing and the factors that determine individual settlement amounts.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Phase 1: Case Filing and MDL Enrollment

The first step for a PowerPort plaintiff is filing a complaint in federal court — in any federal district — and serving it on Becton Dickinson. The case is then transferred to MDL 3:22-md-03062 in the District of Arizona by the JPML. Within the MDL, each plaintiff completes a Plaintiff Fact Sheet (PFS) within the deadline set by the court's Case Management Order. The PFS asks detailed questions about the device implantation, medical history, fracture discovery, imaging findings, treatment, and economic losses. Providing complete, accurate, and well-documented PFS responses is critical — deficiencies can result in the case being placed on a delinquency list or dismissed. Your attorney handles PFS preparation and submission.

Phase 2: Discovery — Documents and Depositions

MDL discovery involves two parallel tracks. Common discovery — conducted by the PSC on behalf of all plaintiffs — addresses BD's internal documents: materials science testing of the polyurethane catheter, adverse event reports, regulatory submissions, communications between engineering and legal teams, and post-market surveillance data. Individual discovery — specific to individual plaintiffs' cases — involves obtaining each plaintiff's medical records, device records, and identifying treating physician witnesses. Common discovery depositions of BD corporate witnesses (engineers, regulatory affairs personnel, marketing executives) are conducted once but available to all plaintiffs. General causation expert reports — addressing whether the PowerPort polyurethane catheter can cause the alleged injuries — are disclosed and challenged through Daubert motions heard by the MDL judge.

Phase 3: Bellwether Trials and Settlement Pressure

Bellwether trials are the engine of MDL settlements. The court selects a pool of representative cases — chosen to reflect the range of injury severity, causation theories, and plaintiff demographics in the MDL — and schedules them for trial before the MDL judge or remand to their home districts. Bellwether verdicts, whether plaintiff or defense wins, provide both sides with concrete data about jury receptivity to the liability and damages evidence. Favorable plaintiff verdicts increase settlement pressure on BD and generate momentum toward global settlement negotiations. Unfavorable verdicts may prompt plaintiffs to accept lower settlement offers.

Phase 4: Global Settlement and Individual Compensation

Following successful bellwether trials, global settlement negotiations begin between BD and the PSC. A global settlement establishes a total fund and a points-based or grid-based allocation system that assigns individual settlement amounts based on injury severity tier, age at injury, economic losses, and other factors. Each individual plaintiff receives a settlement offer based on their position on the allocation grid. The claims administrator — an independent entity appointed to administer the settlement fund — reviews each plaintiff's documentation to verify the injury tier and calculate the individual payment.

Plaintiffs who accept the global settlement sign a release of all claims against BD and Bard in exchange for their individual payment. Plaintiffs who reject the settlement may pursue their cases individually — either in the MDL or remanded to their home district for trial. The vast majority of plaintiffs accept global settlements because they provide a certain recovery without the risk and delay of individual trial. Payments are typically made within 6 to 12 months of settlement acceptance after the claims administrator completes the documentation review process. Your attorney will advise you on whether the settlement offer for your specific case is fair given your injuries and circumstances.

Key data

Data & Statistics

3 SOURCED FIGURES

Average MDL mass tort litigation timeline from MDL establishment to first global settlement: 3-7 years based on comparable device and drug MDLs

Duke Law Center for Judicial Studies, Mass Tort MDL Study 2019

Approximately 95% of MDL plaintiffs accept global settlements rather than proceeding to individual trial

Georgetown Law Journal, MDL Research Project

Global settlement fund size is driven by bellwether trial verdicts — favorable plaintiff verdicts in bellwether cases typically increase total MDL settlement fund by 20-40%

Vanderbilt Law Review, Mass Tort Settlement Analysis

FAQ

Frequently Asked Questions

12 QUESTIONS

A Bard PowerPort is a brand of implantable venous access port (IVAP) made by C.R. Bard (now part of Becton Dickinson). It consists of a small reservoir implanted under the chest skin connected to a polyurethane catheter threaded into a large central vein near the heart. The device provides long-term intravenous access for chemotherapy, blood draws, and medication delivery without repeated needle sticks. Millions of patients have received PowerPort devices, with cancer patients being the primary recipients. The defect at the center of current litigation is the polyurethane catheter's susceptibility to fracturing inside the body over time.

Dive deeper

Related Guides

9 GUIDES

The full investigation

Part of the Bard PowerPort Catheter Investigation